# Pharmacokinetic Properties of Isosorbide-5-mononitrate Under Fasting and Fed Condition in Healthy Male Subjects

> **NCT02101710** · PHASE1 · COMPLETED · sponsor: **UCB Korea Co., Ltd.** · enrollment: 60 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Elantan SR 60 mg
- **DRUG:** Imdur SR 60 mg

## Key facts

- **NCT ID:** NCT02101710
- **Lead sponsor:** UCB Korea Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-06
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2014-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02101710

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02101710, "Pharmacokinetic Properties of Isosorbide-5-mononitrate Under Fasting and Fed Condition in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-20 from https://api.ai-analytics.org/clinical/NCT02101710. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*